United States · Series D startup

Who invested in LeafLink

5 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

B2BCannabis

Valuation: $800M, Oct 2024

Funding summaryUpdated 26 Oct 2026

$156Mraised across 5 rounds since 2015, from 5 sources

$750KSeed$3.0MSeed$17MRound$35MSeries B$100MSeries D
Latest round
Series D, $100MFeb 2023
Step-upi
2.9×
Investors
14 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017201920212023
$750KSeed$3.0MSeed$17MRound$35MSeries B$100MSeries D
First round
Seed, $750K
Nov 2015
Biggest round
$100M
Series D · Feb 2023
Usual gap between rounds
21 months
the median of 4

The rounds

  1. Feb 2023
    Series D$100M3 new2 returning

    Source recorded

  2. Aug 2019
    Series B$35M5 new1 returning

    Reported by Greenmarketreport

  3. Nov 2017
    Round$17M2 new

    Reported by Businessinsider

  4. Apr 2017
    Seed$3.0M4 new
    • Lerer Hippeau Ventures/ Phyto
    • Paul Ciriello
    • Wan Li Zhu
    • Wisdom

    Reported by FinSMEs

  5. Nov 2015
    Seed$750K

    No investor was named in the report.

    From a historical funding recordSEC filing: $825K sold, first sale Nov 2015

Founders and team

From the SEC filings it signed: 2 on the team.

  • Ryan SmithExecutive Officer, Directori
  • Zachary SilvermanExecutive Officeri

On the board, as filediIan LoizeauxJared WeinsteinTa Napoleon

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2015Seed2017Round2017Series B2019Series D2023Lerer HippeauThrive CapitalLFounders FundFJ Labs9Yards CapitalL2 VenturesNosara CapitalWisdom VCLerer Hippeau Ventures/ PhytoNosara Capital/ Casa Verde

Everyone who backed them

Lerer HippeauVC firm3rounds
Thrive CapitalFamily office2rounds, led 1
Founders FundVC firm1round
FJ LabsVC firm1round
9Yards CapitalVC firm1round
L2 VenturesPrivate equity1round
Nosara CapitalVC firm1round
Wisdom VCVC firm1round
Lerer Hippeau Ventures/ Phytono record of our own yet1round
Nosara Capital/ Casa Verdeno record of our own yet1round
Paul Ciriellono record of our own yet1round
Thought Into Action Venturesno record of our own yet1round
Wan Li Zhuno record of our own yet1round
Wisdomno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 8 firms list LeafLink as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

InterplayFamily officePer its own site
Casa Verde CapitalVC firmPer its own site
Muse CapitalVC firmPer its own site
TIA VenturesVC firmPer its own site
Ingenii CapitalGrowth equityPer its own site
Bail Capital LLCInvestorPer its own site
J Heart VenturesVC firmPer its own site
KI capital GmbHCorporate VCPer its own site

Quick answers about LeafLink

Who invested in LeafLink?

LeafLink's investors include Lerer Hippeau, Thrive Capital, Founders Fund, FJ Labs and 9Yards Capital, and 9 more on record.

How much has LeafLink raised?

LeafLink has raised $156M across 5 rounds since 2015.

When did LeafLink last raise?

LeafLink's most recent round was a Series D of $100M in Feb 2023.

What was LeafLink's biggest round?

Its most recent round, $100M in Feb 2023, is also its largest on record.

Who backed LeafLink first?

LeafLink's first round on record, in Apr 2017, was backed by Lerer Hippeau Ventures/ Phyto, Paul Ciriello and Wan Li Zhu and 1 others.

What stage is LeafLink at?

LeafLink's latest named round is a Series D, in Feb 2023.

Where is LeafLink based?

LeafLink is based in the United States.

Who led LeafLink's rounds?

Thrive Capital led the Series B in 2019.

Companies like LeafLink

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.